Earnings call transcript: Accor lifts 2026 profit outlook after strong Q3

Accor’s Q3 revenue rose 9.8% to EUR 1.503 billion (7.7% at constant currency), while RevPAR increased 4.9% with occupancy steady at 71%. The company raised 2026 recurring EBITDA guidance to EUR 1.270–1.285 billion and expects full-year RevPAR growth at the high end of its 2%–2.5% range, but cut net unit growth guidance to 3%–3.5% because of faster closures in its China mid-scale portfolio. Shares fell 1.79% to $46.05 as investors weighed the stronger results and profit outlook against management’s cautious Q4 assumptions.

Analysis

Accor’s upgrade is more useful as evidence of near-term earnings conversion than as proof of a durable demand acceleration: cost control is helping protect EBITDA while RevPAR growth remains rate-led and occupancy is flat. The key test is whether pricing holds without occupancy or booking momentum weakening. With a meaningful share of bookings arriving close to stay dates, current forward visibility does not fully de-risk Q4.

The China closures appear more relevant to reported net-unit growth and confidence in the development engine than to near-term earnings, given the very low fee base described by management. Over time, however, the mix shift matters: replacement openings at higher fees could improve fee economics, but the transition may take years and depends on execution. Conversely, strong pipeline growth is not earnings until hotels open and contribute fees.

The less visible near-term drag is fee timing and mix: franchise conversions, incentive fees, and delayed residential fees can leave management-and-franchise revenue lagging hotel-level RevPAR and unit growth. That limits how much of the operating rebound investors should capitalize immediately. AXP’s expanded Accor partnership is strategically supportive, but the article provides no economics to translate it into an AXP earnings catalyst. Likewise, this update alone does not establish a read-through to Wyndham (WH); brand mix and geography differ.

For AC, the market’s cautious response is understandable rather than clearly mispriced: Q4 assumptions embed difficult comparisons and Middle East weakness, while pricing power is encouraging but not yet validated through a full demand cycle. The thesis improves with stable occupancy and fee growth; it breaks if rate gains begin to impair occupancy or guidance is cut.

Key Decisions for Investors

• AC: Do not chase the guidance raise. Consider a small, staged long only after Q4 trading or the next results confirm that RevPAR pricing is holding without occupancy deterioration; treat this as a conditional catalyst trade, not a structural growth call.
• Monitor AC’s Q4 RevPAR, occupancy, and constant-currency management-and-franchise revenue together. A material deceleration in occupancy or fee growth despite positive RevPAR would falsify the operating-leverage thesis and argue against adding.
• Track China net-unit growth separately from earnings: the near-term EBITDA impact may be limited, but persistent closures without higher-fee replacement openings would weaken the medium-term mix-improvement case.
• No trade in AXP or WH on this item: verify any measurable revenue contribution from the Accor partnership before treating it as an AXP catalyst, and do not infer Wyndham read-through from Accor’s update.